X0609 4 2026-09-08 0 0001601830 RECURSION PHARMACEUTICALS, INC. RXRX 0002020969 Khan Najat false 41 S. RIO GRANDE STREET SALT LAKE CITY UT 84101 1 1 0 0 CEO and President 1 Class A Common Stock 2026-09-08 4 S 0 22408 3.5176 D 2072890 D This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2025. This transaction was executed in multiple trades at prices ranging from $3.485 to $3.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. /s/ Kyle Nelson, attorney-in-fact 2026-09-08